These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7103145)

  • 41. Pleural involvement in systemic autoimmune disorders.
    Bouros D; Pneumatikos I; Tzouvelekis A
    Respiration; 2008; 75(4):361-71. PubMed ID: 18477860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined Pulmonary Fibrosis and Emphysema Preceding Lupus Pleuritis.
    Kamiya Y; Toyoshima M; Akiyama N; Suda T
    Intern Med; 2016; 55(7):783-6. PubMed ID: 27041165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of systemic lupus erythematosus presenting with protein-losing enteropathy.
    Türkçapar N; Ozyüncü N; Cinar K; Ensari A; Küçük O; Idilman R; Duman N; Ozden A
    Turk J Gastroenterol; 2006 Sep; 17(3):226-30. PubMed ID: 16941261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin.
    Sherer Y; Langevitz P; Levy Y; Fabrizzi F; Shoenfeld Y
    Lupus; 1999; 8(4):324-7. PubMed ID: 10413213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical observations on C3 and CH50 in the serum of patients with systemic lupus erythematosus].
    Jin A
    Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):36-8. PubMed ID: 6430492
    [No Abstract]   [Full Text] [Related]  

  • 46. [Acute pulmonary disease in systemic lupus erythematosus successfully treated with prednisolone pulse therapy].
    Kashiwabara K; Syouda S; Narushima K; Nakamura H; Yagyu H; Kiguchi T; Kusama H; Matsuoka K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):106-10. PubMed ID: 8717302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Erythrosedimentation and serum complement as parameters of clinical activity in systemic lupus erythematosus.
    Rivero I; Moravenik M; Diumenjo MS; Vannucci J
    Rev Clin Esp; 1977 Dec; 147(5):495-8. PubMed ID: 605255
    [No Abstract]   [Full Text] [Related]  

  • 48. [Immunologic diagnosis of joint diseases].
    Vischer TL
    Schweiz Med Wochenschr; 1982 Jun; 112(25):905-9. PubMed ID: 7051278
    [No Abstract]   [Full Text] [Related]  

  • 49. Systemic lupus erythematosus presenting with recurrent pleural effusion without any systemic manifestation.
    Mitra B; Sengupta P; Saha K; Sarkar N; Pal J
    J Assoc Physicians India; 2005 Dec; 53():1073-6. PubMed ID: 16572968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases.
    Ramos-Casals M; Jara LJ; Medina F; Rosas J; Calvo-Alen J; Mañá J; Anaya JM; Font J;
    J Intern Med; 2005 Jun; 257(6):549-57. PubMed ID: 15910559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic lupus erythematosus presenting as chronic serositis with no demonstrable antinuclear antibodies.
    Ferreiro JE; Reiter WM; Saldana MJ
    Am J Med; 1984 Jun; 76(6):1100-5. PubMed ID: 6610353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H; Leung JC; Chan LY; Chan TM; Lai KN
    Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relation between various autoimmune antibodies and serum complement levels in patients with systemic lupus erythematosus].
    Okumura N; Kumagai T; Kameko M; Kanai M
    Rinsho Byori; 1986 Aug; 34(8):967-72. PubMed ID: 3784036
    [No Abstract]   [Full Text] [Related]  

  • 54. [Intervention of heparin in immunological phenomena: reversibility of the nuclear antigen and antinuclear antibody reaction in systemic lupus erythematosus].
    Bardare M; Menghi P
    Boll Soc Ital Biol Sper; 1965 Jul; 41(13):713-5. PubMed ID: 4164914
    [No Abstract]   [Full Text] [Related]  

  • 55. Serum complement, rheumatoid factor, and other serum proteins in rheumatoid disease and systemic lupus erythematosus.
    ELLIS HA; FELIX-DAVIES D
    Ann Rheum Dis; 1959 Sep; 18(3):215-24. PubMed ID: 13820041
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical utility of common serum rheumatologic tests.
    Lane SK; Gravel JW
    Am Fam Physician; 2002 Mar; 65(6):1073-80. PubMed ID: 11925083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunoserological follow-up and clinical finding in SLE].
    Naganawa C; Kojima I; Ozawa A
    Rinsho Byori; 1971 Aug; 19():Suppl:478. PubMed ID: 5316596
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pathogenesis of complement decrease in the synovial fluid in rheumatoid arthritis and disseminated lupus erythematosus].
    Peltier AP; de Sèze S
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):61-8. PubMed ID: 5549169
    [No Abstract]   [Full Text] [Related]  

  • 60. Serum complement, kidney disease and infection in patients with systemic lupus erythematosus.
    Futrakul P; Campbell RA
    J Med Assoc Thai; 1970 May; 53(5):346-8. PubMed ID: 5505655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.